Bristol-Myers Squibb Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Wall Street ends choppy session lower as tech shares drop
Bristol-Myers Squibb (BMY) PT Raised to $80 at UBS
April 29, 2016 8:16 AM EDTUBS analyst Marc Goodman reiterated a Buy rating and boosted his price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $80.00 (from $73.00) following results.
Goodman highlighted:
"Regarding Opdivo, mgt indicated that (1) it has >80% dollar share in US PD-1 category, and comparable shares in... More
